| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/09/2005 | CN1575792A Method for stablizing protein medicine and its application in microball preparation |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188523C Blue-green alga shuttle plasmid expression vector and method for expressing thymison alpha1 |
| 02/09/2005 | CN1188517C Method of purifying thrombin-like protease enzymes obtained from snake venom |
| 02/09/2005 | CN1188516C Coded nucleotide sequence of recombinant nattokinase and process for producing the same nattokinase |
| 02/09/2005 | CN1188422C Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) Propylcarbamate |
| 02/09/2005 | CN1188172C G-CSF conjugates |
| 02/09/2005 | CN1188166C Drug for treating skin disease and preparation method thereof |
| 02/09/2005 | CN1188165C Method for treating pain by peripheral administration of neurotoxin |
| 02/09/2005 | CN1188164C Compositions and method for regulating phagocytosis and ICAM-1 expression |
| 02/09/2005 | CN1188137C Use of erythrogenin and molecule with active EPO receptor ability or analog EPO activation in pharmacy |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/09/2005 | CN1188031C Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 02/08/2005 | US6852848 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/08/2005 | US6852847 B7 nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins and inhibitors of such proteins or nucleic acid molecules |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 02/08/2005 | US6852835 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses |
| 02/08/2005 | US6852818 Molecularly imprinted polymers produced by template polymerization |
| 02/08/2005 | US6852755 This invention pertains to nitrogen mustard compounds (Formula (II)) and prodrugs therefor (Formula (I)), methods for their preparation, pharmaceutical compositions comprising such compounds, and the use of such compounds and |
| 02/08/2005 | US6852744 Pyrrolidine derivatives and their use as chymase inhibitor |
| 02/08/2005 | US6852722 Administering a growth hormone secretagogue. |
| 02/08/2005 | US6852700 Colostrinin, and uses thereof |
| 02/08/2005 | US6852698 Free radical scavengers or promoters thereof as therapeutic adjuvants in preterm parturition |
| 02/08/2005 | US6852697 Peptides for treatment of inflammation and shock |
| 02/08/2005 | US6852696 Inhibitors of glycosaminoglycans |
| 02/08/2005 | US6852695 For therapy of hyperglycemic disorders |
| 02/08/2005 | US6852694 Stabilized insulin formulations |
| 02/08/2005 | US6852693 Compositions and methods for promoting lipid mobilization in humans |
| 02/08/2005 | US6852692 Adrenomedullin composition of the present invention may be used to ameliorate a urination disorder. The urination disorder may be a urinary incontinence selected from the group consisting of urge incontinence, reflex incontinence and |
| 02/08/2005 | US6852691 Anti-angiogenic peptides and methods of use thereof |
| 02/08/2005 | US6852690 Improved parenteral administration of nutrients is provided. The method comprises co- administration of nutrients, especially carbohydrates, and an insulinotropic peptide, or its derivatives, analogs, and fragments. The method and |
| 02/08/2005 | US6852689 Methods for administration of antibiotics |
| 02/08/2005 | US6852688 Compositions for treating diabetic retinopathy and methods of using same |
| 02/08/2005 | US6852687 Method for inhibiting apoptosis |
| 02/08/2005 | US6852686 Methods for ameliorating icthyosiform skin diseases |
| 02/08/2005 | US6852685 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation |
| 02/08/2005 | US6852538 Response element (RE) for Nur family members |
| 02/08/2005 | US6852537 Transgenic circulating endothelial cells |
| 02/08/2005 | US6852536 Antisense modulation of CD36L 1 expression |
| 02/08/2005 | US6852535 A transcribed non-naturally occurring RNA molecule comprising a desired RNA molecule, wherein the 3' region of the RNA is able to base-pair with at least 8 bases at the 5' terminus of the same RNA molecule |
| 02/08/2005 | US6852520 DSP-2 dual-specificity phosphatase |
| 02/08/2005 | US6852519 MAP/extracellular signal-regulated kinases which effect protein phosphorylation; biochips |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852509 Anti-P53 single-chain antibody fragments and their uses |
| 02/08/2005 | US6852508 Chemokine with amino-terminal modifications |
| 02/08/2005 | US6852507 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 02/08/2005 | US6852497 Fusion protein |
| 02/08/2005 | US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence |
| 02/08/2005 | US6852338 Isolation of blood and lymph from molluscs; obtain molluscs, remove blood and lymph, evaluate tissues |
| 02/08/2005 | US6852323 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| 02/08/2005 | US6852320 T cell inhibitory receptor compositions and uses thereof |
| 02/08/2005 | US6852319 Generation of antibody with preferential binding activity; obtain plant, transform with nucleotide sequences coding immunoglobulin, express nucleotide sequences, recover imunoglobulin |
| 02/08/2005 | US6852318 Comprises contacting tissue with integrin |
| 02/08/2005 | US6852316 Cancer treatment |
| 02/08/2005 | US6852314 IFN-β liquid formulations |
| 02/08/2005 | US6852313 For treating blood disorders; cytokines/interleukins |
| 02/08/2005 | US6852311 Ophthalmic ointments for treating infective eye disease |
| 02/08/2005 | US6852308 Iodinated and/or brominated derivatives of aromatic dihydroxy monomers are prepared and polymerized to form radio-opaque polymers. The monomers may also be copolymerized with other dihydroxy monomers. The iodinated and brominated aromatic |
| 02/08/2005 | US6852230 Method for the manufacture of compositions containing low concentrations of salts |
| 02/08/2005 | CA2314313C Stabilized teriparatide solutions |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005010205A2 Biomarkers fo aggrecanase activity |
| 02/03/2005 | WO2005010190A1 Ssx-2 peptides presented by hla class ii molucules |
| 02/03/2005 | WO2005010185A1 Rna capable of inhibiting expression of klf5 gene |
| 02/03/2005 | WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/03/2005 | WO2005010152A2 Human mast cell-expressed membrane protein |
| 02/03/2005 | WO2005010044A2 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | WO2005010043A1 A method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 02/03/2005 | WO2005010040A1 Eimeria tenella antigen for immunotherapy of coccidiosis |
| 02/03/2005 | WO2005010038A2 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 02/03/2005 | WO2005010037A1 Polypeptides, nucleic acids coding therefor, from the mold fungus cladosporium herbarum and the production and use thereof in diagnosis and therapy |
| 02/03/2005 | WO2005010036A1 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 02/03/2005 | WO2005010030A2 C5a receptor antagonists |
| 02/03/2005 | WO2005010029A1 Aza-peptide macrocyclic hepatitis c serine protease inhibitors |
| 02/03/2005 | WO2005010027A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/03/2005 | WO2005010024A2 Potent peptide inhibitors and methods of use |
| 02/03/2005 | WO2005010022A2 Agonist polypeptide of receptor for zot and zonulin |
| 02/03/2005 | WO2005009948A2 Peptide inhibitors of beta-lactamases |
| 02/03/2005 | WO2005009498A2 Decellularized bone marrow extracellular matrix |
| 02/03/2005 | WO2005009475A1 Medicinal preparation containing component originating in bacteruim belonging to the genus clostridium |
| 02/03/2005 | WO2005009468A1 Remedy for cartilage-related diseases |
| 02/03/2005 | WO2005009461A1 Factor vii activating protease (fsap) polypeptides for the treatment of angiogenesis-related disorders |
| 02/03/2005 | WO2005009460A2 Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer |
| 02/03/2005 | WO2005009459A1 Ophthalmic compositions comprising trefoil factor family peptides |
| 02/03/2005 | WO2005009458A1 Use of xmp-629 for the treatment of acne |
| 02/03/2005 | WO2005009457A1 Rdp58 compositions and methods for inhibiting vascularization of cell populations |
| 02/03/2005 | WO2005009456A2 Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment |
| 02/03/2005 | WO2005009455A1 Peptide compound exhibiting an immunoregulatory property |
| 02/03/2005 | WO2005009449A1 Pharmaceutical active substance against warts, herpes simplex and herpes zoster |
| 02/03/2005 | WO2005009415A2 Novel method for microparticles production |
| 02/03/2005 | WO2005009396A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/03/2005 | WO2005009394A2 Drug delivery in the nervous system |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009358A2 Conformationally constrained parathyroid hormone (pth) analogs |